AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 201 min read$ICHR

BARROS PHILIP RYAN SR. sold $81K of ICHR

BARROS PHILIP RYAN SR. (Chief Executive Officer) sold 1,314 shares of ICHOR HOLDINGS, LTD. (ICHR) at an average of $61.88 ($61.39–$62.67) across 2 trades on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · BARROS PHILIP RYAN SR.
Published Aug 20, 2026, 9:24 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ICHR
Neutral
high confidence
Mentioned
$ICHR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICHRNeutralLow
01

Why it matters

The disclosed sale is routine and pre-arranged, offering little new insight for traders.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential tax planning or portfolio rebalancing motives not evident.

Relevance 2/10Novelty 4/10Timing: filed 2026-08-20

Background

Form 4 filing reports insider transactions required by SEC regulations.

Company-level read

Ticker impact

$ICHRNeutralHigh confidence
Context

CEO Barros Philip Ryan Sr. sold 1,314 shares for $81,306 via a 10b5-1 plan, reducing his stake to 161,562 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale amount is small relative to market cap and follows a pre-arranged plan, indicating no new negative information.

Market effects

Sector

None; insider sale does not affect the broader biotech sector.

Regional

No regional impact.

Global

Minimal; limited to ICHOR shareholders.

Counterpoint

What could challenge this read

The sale could signal upcoming negative news not yet disclosed.

Key entities

  • Person
    Barros Philip Ryan Sr.

    Chief Executive Officer of ICHOR HOLDINGS, LTD.

  • Company
    ICHR

    Ichor Holdings, a biotech company listed on NASDAQ.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ICHR insider trading history →

Related articles

AUG 5
$ICHRMedAI 8/10

Ichor Holdings, Ltd. Q2 2026 Earnings Call Summary

Ichor Holdings reported Q2 2026 revenue up 15% sequentially, with gross margin rising 130 bps to 14.1%. Management attributed a Q2 revenue shortfall to brief flow-control part shortages resolved after quarter end, shifting volume to Q3. It expects sequential revenue growth above 10% for the next two quarters and full-year 2026 revenue up at least 30% vs 2025, with gross margin gains of 100 bps per quarter. An ATM raised $195m net proceeds.

yahoo.com7 min
AUG 3
$ICHRMed

Why is Ichor Holdings stock sliding today?

Ichor Holdings (ICHR) shares fell 12.9% in after-hours after its Q2 2026 results. The company reported adjusted EPS of $0.34 on revenue of $294.8M, beating consensus, with gross margin at 14.1%. Operating cash flow was -$15.9M and it completed a $200M at-the-market offering. Q3 revenue guidance was $315M-$345M.

investing.com4 min
AUG 3
$PLTRMed

After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR

Investing.com’s after-hours movers report highlights Palantir (PLTR) up 10% after Q2 EPS of $0.41 and $1.94B revenue, with 2026 revenue guidance raised to $8.15–$8.158B. Snap (SNAP) rose 9.6% on Q2 revenue $1.6B and Q3 guidance $1.7–$1.74B. Backblaze (BLZE) gained 16% on Q2 beat and raised 2026 revenue to $172–$174M. ON (ON) +5%, ICHR -11%, WGS -7%, WHR -4%.

investing.com6 min
MAY 27
$ICHRMedAI 9/10

Ichor Holdings, Ltd. $ICHR Shares Bought by Royce & Associates LP

Royce & Associates LP increased its Ichor Holdings (NASDAQ:ICHR) stake by 48.5% in Q4 to 1,449,082 shares, worth $26.71M, after buying 473,440 shares, according to SEC filings cited by HoldingsChannel. Other institutions also added shares. CEO Philip Ryan Sr. Barros sold 21,000 shares at $46.63. Analysts raised price targets; consensus average is $64.57.

tickerreport.com3 min